HOME >> BIOLOGY >> NEWS
New Brookhaven Lab study shows how ritalin works

UPTON, NY New research on Ritalin, a drug prescribed to millions of American children each year with Attention Deficit Hyperactivity Disorder (ADHD), shows for the first time how the drug acts in the human brain and why it is so effective.

The findings are reported in the January 15 issue of the Journal of Neuroscience by researchers from the U.S. Department of Energy's Brookhaven National Laboratory. The publication can be found on the Web at http://www.jneurosci.org/cgi/content/full/20014896.

Although Ritalin has been used for more than 40 years as a successful treatment for ADHD, minimal information has been gathered to date on exactly how the drug works in the brain, outside of limited animal studies. This latest study, on humans, indicates that Ritalin significantly increases levels of dopamine in the brain, thereby stimulating attention and motivational circuits that enhance ones ability to focus and complete tasks.

"For the first time, we are seeing that Ritalin given at doses commonly used to treat children with ADHD significantly increases levels of dopamine in the brain," said psychiatrist Nora Volkow, head of the research team and Associate Laboratory Director for Life Sciences at Brookhaven Lab. "This combination the ability to increase motivation and also directly activate circuits of attention is likely to be key to the beneficial effects of Ritalin."

Earlier animal and limited human studies had indicated that Ritalin interferes with the recycling of dopamine within the brain by blocking dopamine transporters. However, since these earlier studies involved injection of much higher doses of Ritalin, it was unclear whether the drug would increase extracellular dopamine at doses used therapeutically for children.

Using a technique called positron emission tomography, or PET, researchers at Brookhavens Center for Imaging and Neurosciences studied dopamine levels i
'"/>

Contact: Peter Genzer
genzer@bnl.gov
631-344-3174
DOE/Brookhaven National Laboratory
15-Jan-2001


Page: 1 2 3

Related biology news :

1. Brookhaven lab biophysicist F. William Studier wins R&D 100 award
2. Workshop for new synchrotron light source at Brookhaven
3. Brookhaven Lab expects $30 million to support life sciences
4. Brookhaven Lab develops ThraxVac to clean up anthrax
5. Brookhaven Lab & Battelle collaborate on research that may lead to novel anti-microbial drugs
6. Rice, Brookhaven physicists decode initial stage of cell fusion
7. Brookhaven Lab scientist wins Environmental Mutagen Society Award
8. Brookhaven Spotlights: News from the National Synchrotron Light Source
9. Enzyme studies at Brookhaven Lab may lead to new antiviral agents
10. Brookhaven scientists determine key Lyme disease protein structure
11. New test for radiation damage to DNA developed at Brookhaven Lab

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2020)... , ... May 15, 2020 , ... The National Institutes ... property law firm based in Frederick, Maryland and Tysons Corner, Virginia, to provide patent ... biotechnology and a another in the field of chemistry. The firm is one of ...
(Date:5/11/2020)... ... May 11, 2020 , ... Octagos ... for patients with implanted cardiac devices. The Octagos software allows healthcare professionals access ... software greatly simplifies the management of remote transmissions and at the same time ...
(Date:5/1/2020)... ... April 30, 2020 , ... Flagship Biosciences ... Consulting Inc., a biopharmaceutical and regulatory services advisor. The companies now deliver regulatory ... and Corritori are taking a collaborative approach to empower more confident and informed ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... 05, 2020 , ... Smart Meter, a diabetes ... iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose Monitor and Remote Patient ... and broadest cellular connectivity available, to provide patients with seamless connectivity to their ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular diagnostics company ... Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO Dr. ... 2014 before stepping into the CEO role in 2017. , In concert ...
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading developer ... SneakPeek Early Gender DNA Tests sold in March, just months after attaining ... an ecommerce product, where a mom could order her kit online, collect a DNA ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... method using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that decreases PCR ... increased samples per run, and standard, affordable laboratory equipment, a qualitative protocol ...
Breaking Biology Technology:
Cached News: